Effect of migration on fertility and family planning: The case of Kayseri in Türkiye.

Many factors such as religious beliefs, cultural structure, the perspective of the host country toward refugees, and the course of the migration process can affect the family planning and fertility behaviors of refugees. This study aimed to determine the knowledge, attitudes, and behaviors of Syrian refugee pregnant women in the Kayseri province of Türkiye regarding fertility characteristics and family planning. This descriptive and cross-sectional study was conducted with 290 pregnant Syrian refugee women.

Effects of different PCOS phenotypes on placental three-dimensional power Doppler indices and placental volume during the first trimester.

Introduction: The aim of the present study was to evaluate the effects of different polycystic ovary syndrome (PCOS) phenotypes using first-trimester placental three-dimensional power Doppler indices and placental volume.

Methods: In this prospective case-control study, 170 pregnant women who met the inclusion criteria were divided into five groups according to PCOS phenotype: non-PCOS control (n = 34), PCOS phenotype A (n = 34), PCOS phenotype B (n = 34), PCOS phenotype C (n = 34), and PCOS phenotype D (n = 34). The primary outcomes determined in the present study were the differences in placental volume and placental flow index (FI), vascularization flow index (VFI), vascularization index (VI), and uterine artery pulsatility index (PI) betweenthe PCOS groups and control group.

Fetal Diaphragmatic Excursion Is Decreased in Hospitalized Pregnant Women Infected with COVID-19 during the Second and Third Trimesters.

Objective: In the present study, we aimed to evaluate coronavirus disease 2019 (COVID-19) infection effects on fetal diaphragm thickness and diaphragmatic excursion, which together show the quality of diaphragmatic contractions.

Study Design: One hundred and ninety-two pregnant women were included in this prospective case-control study. Patients were divided into four groups according to their COVID-19 infection history in their second or third trimester: hospitalized COVID-19-infected pregnant women group ( = 48), outpatient COVID-19-infected pregnant women group ( = 48), common cold (COVID-19 polymerase chain reaction negative) pregnant women group ( = 48), and noninfected healthy controls ( = 48).